Number of Shares
2.06 Mil
Current Holdings Value*
kr177.66 Mil
% of Portfolio
2.29%
Total Estimate Gain
kr598.13 Mil
% of Total Estimate Gain
39.84%

Global Growth Fund's Novo Nordisk AS Holding Summary

As of 2024-12-31, AMERICAN FUNDS INSURANCE SERIES held 2.06 Mil shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr177.66 Mil. This investment constitutes 2.29% of their stock portfolio, and AMERICAN FUNDS INSURANCE SERIES now holds 0.05% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2022Q2. And since then Global Growth Fund has made 5 purchases of OCSE:NOVO B, at an average price of kr420.22, for a total of 3.57 Mil shares. In addition, there have been 1 sales at an average price of kr811.65 for 1.51 Mil shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, Global Growth Fund's estimated gain on his OCSE:NOVO B holdings is kr598.13 Mil, reflecting a 39.84% gain to date.

Global Growth Fund OCSE:NOVO B (kr423.90) Holding Chart

Global Growth Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1